Tellgen Corporation Tellgen Corporation

Tellgen Corporation

300642

Rangering i aksjer #13949
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of... Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Aksjekurs
$2.59
Markedsverdi
$420.62M
Endring (1 dag)
-9.56%
Endring (1 år)
-28.57%
Land
CN
Handel Tellgen Corporation (300642)

Kategori

Healthcare
Aksjeprishistorikk for Tellgen Corporation (300642)
Høyeste sluttskurs: $2.80 den 2026-10-01

Laveste sluttskurs: $3.59 den 2017-04-01
Aksjeprishistorikk for Tellgen Corporation fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -7.04%
2025 24.20%
2024 -14.78%
2023 -20.19%
2022 -35.03%
2021 2.84%
2020 47.58%
2019 -6.06%
2018 -34.45%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$102.65 -19.77%
US
$96.45 0.57%
IE
$307.12 -20.92%
US
$46.02 -55.69%
US
$47.05 -17.88%
DE